Fresenius Medical Care | FME

Stock Price
41.99
Daily Change
0.28 0.67%
Monthly
2.61%
Yearly
16.83%
Q3 Forecast
41.66

Peers Price Chg Day Year Date
Akzo Nobel 60.36 1.26 2.13% 3.71% Sep/06
Alcon AG 64.08 0.62 0.98% -19.15% Sep/05
AstraZeneca 12,090.00 -98.00 -0.80% -4.89% Sep/06
Bayer 28.16 -0.42 -1.47% -1.83% Sep/06
Beiersdorf 97.32 -1.58 -1.60% -23.97% Sep/06
DaVita Healthcare Partners 137.87 2.31 1.70% -8.13% Sep/05
Essilor 259.60 -0.60 -0.23% 22.74% Sep/06
E.ON 15.18 0.25 1.68% 13.04% Sep/06
Fresenius Medical Care 41.99 0.28 0.67% 16.83% Sep/06
Fresenius 46.82 -0.36 -0.76% 39.22% Sep/06
Genmab 1,751.50 6.50 0.37% -5.83% Sep/05
Getinge 209.80 0.80 0.38% -3.98% Sep/05
Givaudan 3,504.00 21.00 0.60% -20.53% Sep/05
GN Store Nord 113.95 2.45 2.20% -30.88% Sep/05
GRIFOLS 12.30 0.02 0.16% 32.17% Sep/05
GlaxoSmithKline 1,476.00 7.00 0.48% -10.63% Sep/05
Hikma Pharmaceutical 1,720.00 -3.00 -0.17% -12.07% Sep/05
Lonza 577.40 -0.80 -0.14% 7.68% Sep/05
Merck 109.55 1.05 0.97% -35.52% Sep/06
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Philips 23.80 0.02 0.08% -12.63% Sep/06
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
RWE 35.02 0.36 1.04% 5.58% Sep/06
Sanofi 79.50 0.54 0.68% -24.83% Sep/06
SAP 228.25 -4.95 -2.12% 18.52% Sep/06
Smith & Nephew 1,416.00 6.00 0.43% 18.15% Sep/05
Demant 248.80 8.80 3.67% -11.27% Sep/05

Indexes Price Day Year Date
DE40 23707 -173.35 -0.73% 28.54% Sep/08

Fresenius Medical Care traded at 41.99 this Saturday September 6th, increasing 0.28 or 0.67 percent since the previous trading session. Looking back, over the last four weeks, Fresenius Medical Care gained 2.61 percent. Over the last 12 months, its price rose by 16.83 percent. Looking ahead, we forecast Fresenius Medical Care to be priced at 41.66 by the end of this quarter and at 40.70 in one year, according to Trading Economics global macro models projections and analysts expectations.

Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.